卵母细胞冷冻技术评估研究进展  

Progress on the oocyte cryopreservation technology assessment

作　　者：白符[1] 刘畅[1] 张懿心 马艺[1] 王冬颖[1] 张亚楠 Bai Fu;Liu Chang;Zhang Yixin;Ma Yi;Wang Dongying;Zhang Yanan(National Center for Women and Children's Health,Chinese Center for Disease Control and Prevention,Beijing 100081,China)

机构地区：[1]中国疾病预防控制中心妇幼保健中心,北京100081

出　　处：《中华预防医学杂志》2020年第5期577-580,共4页Chinese Journal of Preventive Medicine

基　　金：国家重点研发计划(2018YFC1002106)。

摘　　要：卵母细胞冷冻技术作为女性生育力保存的一种方式,越来越受到社会的关注。卵母细胞冷冻技术评估研究进展是推进卵母细胞冷冻技术临床应用的重要科学依据。本文通过文献回顾,从卫生技术评估的视角,围绕卵母细胞冷冻技术母体安全性、子代安全性,技术有效性以及社会伦理性等方面的评估研究进展进行了阐述。基于现有研究证据证实了卵母细胞冷冻技术的近期安全性和有效性,然而远期的母体和子代安全性仍然需要长期的随访观察数据证实。关于人类辅助生殖技术的社会伦理学评估方法的研究尚处于探索阶段,需要建立关于卵母细胞冷冻技术在内的人类辅助生殖技术社会伦理学评估方法和体系。As a way of female fertility preservation,oocyte cryopreservation technology(OCT)has attracted more attention from the society.The health technology assessment(HTA)research progresses on OCT are important evidence basis for OCT clinical application promotion.Literatures on the maternal and offspring safety,efficacy and social ethics assessment of OCT were reviewed in this paper.Based on the current OCT evaluation evidence,short-term safety and effectiveness were confirmed,but long-term maternal and child safety should be testified in a large scale follow-up study.Social ethics evaluation methods of human assisted reproductive technology(ART)research were still in the exploratory stage.Therefore,it is necessary to establish the social ethics evaluation methods and system of human ART,including OCT,in China.

关 键 词：卵母细胞 冷冻 社会伦理性 

分 类 号：R714[医药卫生—妇产科学]